Central Sleep Apnoea – Guidelines and recommendations into identifying and reporting of CSA
Sefam UK recently published a series of 5 blogs on Central Sleep Apnoea (CSA) which is much less prevalent than […]
Sefam UK recently published a series of 5 blogs on Central Sleep Apnoea (CSA) which is much less prevalent than […]
Reporting Central Apnoeas and Hypopnoeas in Sefam Connect and Sefam Analyse remote monitoring software. Sefam Connect is our cloud based
In a previous article, we discussed the French consensus on central sleep apnea and hypopnea syndrome (SAHCS) in adults. Part
In 2012, the American Academy of Sleep Medicine (AASM) issued guidelines for treating Central Sleep Apnea Syndromes (CSA) in adults.
Signs and Symptoms of Central Sleep Apnea (CSA): CSA is often a component of severe sleep apnea hypopnea syndrome (SAHS),
Central Sleep Apnea and Its Phenotypes: The Importance of Screening and Treatment Obstructive sleep apnea (OSA) is the most common
A Legacy of Innovation Founded in 1982, SEFAM has been a leader in sleep medicine innovation. Their development of Europe’s
Sleep apnoea is a common condition that is unrecognised and is thought to affect millions of people globally. Multiple breathing
Upper Airway Resistance Syndrome (UARS) is a sleep disorder characterised by partial obstruction of the upper airways during sleep. Unlike
Understanding the link between sleep-related breathing disorders is crucial in providing personalised care to patients. One often overlooked relationship is
The Sunrise device is an innovative screening and diagnostic device designed to aid in the efficient diagnosis of sleep apnoea
Sleep apnoea syndrome is a prevalent condition that has led to advancements in personalised sleep apnoea therapy, affecting millions globally.